to introduce a non-invasive blood-based screening program for colorectal cancer using Guardant’s Shield™ test. The agreement was set up through Hikma Pharmaceuticals PLC, a multinational ...

Guardant Health (GH) announced an agreement with the Abu Dhabi Public Health Center ADPHC to introduce a non-invasive blood-based screening ...

GH's early success with SHIELD and future potential in multi-cancer detection is promising, but current risks outweigh potential returns, leading to my neutral view. Guardant Health is one of the ...

to introduce a non-invasive blood-based screening program for colorectal cancer using Guardant’s Shield™ test. The agreement was set up through Hikma Pharmaceuticals PLC, a multinational ...

Guardant Health, Inc ... 2 The introduction of the Shield blood test is intended to be a significant step forward in improving screening participation, early detection and outcomes for the ...